Liver transplantation and comprehensive treatment of intrahepatic cholangiocarcinoma
10.3969/j.issn.1674-7445.2021.03.014
- VernacularTitle:肝内胆管癌肝移植及其综合治疗
- Author:
Fengdong WU
1
;
Bin SHI
Author Information
1. Department of Organ Transplantation, the Third Medical Center of Chinese PLA General Hospital, Beijing 100039, China
- Publication Type:Research Article
- Keywords:
Intrahepatic cholangiocarcinoma;
Liver transplantation;
Neoadjuvant therapy;
Targeted therapy;
Transcatheter arterial chemoembolization;
Stereotactic body radiation therapy;
Pemigatinib;
Erdafitinib
- From:
Organ Transplantation
2021;12(3):344-
- CountryChina
- Language:Chinese
-
Abstract:
Liver transplantation is an effective approach to treat intrahepatic cholangiocarcinoma (ICC). It is necessary to strictly control surgical indications of ICC because of its high invasiveness, lymph node metastasis and recurrence rate after liver transplantation. Liver transplantation yields high efficacy for single ICC with a diameterof ≤2 cm. For advanced ICC, neoadjuvant therapies including locoregional treatment and systemic chemotherapy should be initially delivered. According to the response of these neoadjuvant therapies, whether liver transplantation should be performed can be determined, and individualized adjuvant therapy should be delivered after operation. At present, multiple gene mutation targets and targeted therapeutic drugs for cholangiocarcinoma have been identified. Comprehensive treatment before and after liver transplantation may expand surgical indications of liver transplantation for ICC and improve clinical prognosis of the recipients. In this article, liver transplantation for ICC, neoadjuvant therapy before liver transplantation, postoperative adjuvant therapy and targeted therapy for ICC were reviewed.
